# Novel Injectable Drug Cuts Visceral Fat in Phase 2 Trial

> **Open Intelligence Dossier** · First detected: 2026-10-02 20:40 UTC · Category: Health

## Executive Summary
5 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.

## Intelligence Brief
"Novel Injectable Drug Cuts Visceral Fat in Phase 2 Trial" is generating significant coverage in the Health category, with 5 articles from 5 distinct sources tracked by PULSE so far.


Outlets currently covering the story include kkam.com, DongA Science, Medical Xpress and New York Post. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.


This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.

## Multi-Source Evidence Table
| Source Outlet | Headline | Verification URL |
|---|---|---|
| kkam.com | A new drug allows you to lose your gut without Ozempic or surgery! | [Source Link](https://news.google.com/rss/articles/CBMickFVX3lxTFBOTGNxU3VWTUY2cWg0X21nU0ZyUUZHNzZOMWp3dm9hZ2JJbm0yd0dzZVBFWGZ3bVlCckVLQmxnNDBhb1pDM2RfZVNNSENnSEhEbS1LQmdDakdXcGI2ZzRuX3o2c2MtTDNZdWlDTzl1blJYUQ?oc=5) |
| DongA Science | Next-generation obesity drug CBL-514 enters phase 3, destroying fat cells without rebound | [Source Link](https://news.google.com/rss/articles/CBMiVEFVX3lxTFBRbTVRUGtyWEg0ZDlqRFZ3OGt4UW1mWmx3dm5vMUVEMUczTnF1M3dnYzRHdXlXemROZWlwWmYzWVUtWENfQ2N3a3Voc00zb0Z6ZEt5Qw?oc=5) |
| Medical Xpress | New weight-loss injection targets fat cells: CBL-514 selectively induces apoptosis of fat cells | [Source Link](https://news.google.com/rss/articles/CBMieEFVX3lxTE5qQmlnQjNOS0FqT3dkT2ZBbWJzY3Bmcl92OTBsZ0hfZTc1QWs3d0hTVGtXUWZNejYxVTd0NHZpT3o5dDNKdV9EVEhTYjBPWFZmWXBKSHhTb2JMXzFaejREOU93QkZfSE0tNi1FTUpuVnMwcUhLRDZXcg?oc=5) |
| New York Post | New weight-loss drug could give you a ‘flatter stomach’ in mere weeks — and unlike Ozempic, it targets belly fat directly | [Source Link](https://news.google.com/rss/articles/CBMitAFBVV95cUxNOEN4bTFod1NKbmxiR2pwVU1OVzM5VVR6TV9wMU8tSkFuQnF1VUMwMEFNMjQzTjZKNmE0U1NELUkwMkR3R3RTbFVoX3o4WmowaDlUZUhCT0lIYWdzMmNrOE1BLUQ5eTlfRHB3U0swRS16NE9oNVRCYUJwd3NvdER4d2c4bkM1UjVnVlYwMHpkNkdCaXdBWWY1SGdRZjA3TnZJcExkVE1YU1Q4bjl0bi00MkRkUWw?oc=5) |
| Medscape | Novel Injectable Drug Cuts Visceral Fat in Phase 2 Trial | [Source Link](https://news.google.com/rss/articles/CBMipgFBVV95cUxOd2lEclNSVFlvWXJ5ZTVaVGMxSG5kX2F2dk00U1Job3NJcHBNbEUxSGp1RHBvRDNMWVhGT3ZWNGZfQV96YVZyMnZVc1J5LUN3NUplT3NTNE5VbWFOTEt1bWc1YVQ3QmctUnR5V0ttQ2IzSUJ2dHc2cHRyMkRqVnUxWUhZMzZMMWJjM2R2akpiNF9TSW1fb05UbWc5LU56cW9OUnotZVNB?oc=5) |

---
*Canonical Source: https://pulse.byoviral.com/trend/2026-10-02/novel-injectable-drug-cuts-visceral-fat-in-phase-2-trial*